OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

From basic researches to new achievements in therapeutic strategies of KRAS-driven cancers
Mahsa Saliani, Razieh Jalal, Mohammad Reza Ahmadian
Cancer Biology and Medicine (2019) Vol. 16, Iss. 3, pp. 435-461
Open Access | Times Cited: 25

Showing 25 citing articles:

Connecting the Dots: LncRNAs in the KRAS Pathway and Cancer
Mudasir Maqbool, Md Sadique Hussain, Ajay Singh Bisht, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155570-155570
Closed Access | Times Cited: 10

Stopping the beating heart of cancer: KRAS reviewed
Lorenz Herdeis, Daniel Gerlach, Darryl B. McConnell, et al.
Current Opinion in Structural Biology (2021) Vol. 71, pp. 136-147
Open Access | Times Cited: 45

KRAS: A Druggable Target in Colon Cancer Patients
Francesca Negri, Lorena Bottarelli, Gian Luigi de’Angelis, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 8, pp. 4120-4120
Open Access | Times Cited: 37

KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways
Koushik Mondal, Mahesh Kumar Posa, Revathi P Shenoy, et al.
Cells (2024) Vol. 13, Iss. 14, pp. 1221-1221
Open Access | Times Cited: 7

KRAS mutated colorectal cancers with or without PIK3CA mutations: Clinical and molecular profiles inform current and future therapeutics
Ioannis A. Voutsadakis
Critical Reviews in Oncology/Hematology (2023) Vol. 186, pp. 103987-103987
Closed Access | Times Cited: 16

The impact of phosphatases on proliferative and survival signaling in cancer
Goutham Narla, Jaya Sangodkar, Christopher B. Ryder
Cellular and Molecular Life Sciences (2018) Vol. 75, Iss. 15, pp. 2695-2718
Open Access | Times Cited: 33

An overview of recent advancements in small molecules suppression of oncogenic signaling of K-RAS: an updated review
Ahmed Sabt, Haytham O. Tawfik, Eman F. Khaleel, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 3

Differential expression analysis of genes and long non-coding RNAs associated with KRAS mutation in colorectal cancer cells
Mahsa Saliani, Razieh Jalal, Ali Javadmanesh
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13

Structure-based inhibitor design of mutant RAS proteins—a paradigm shift
Kinga Nyíri, Gergely Koppány, Beáta G. Vértessy
Cancer and Metastasis Reviews (2020) Vol. 39, Iss. 4, pp. 1091-1105
Open Access | Times Cited: 19

KRAS-related long noncoding RNAs in human cancers
Mahsa Saliani, Amin Mirzaiebadizi, Ali Javadmanesh, et al.
Cancer Gene Therapy (2021) Vol. 29, Iss. 5, pp. 418-427
Open Access | Times Cited: 14

Clear Cell Adenocarcinoma of Urethra: Clinical and Pathologic Implications and Characterization of Molecular Aberrations
Boram Song, Seok Hyun Lee, Jeong Hwan Park, et al.
Cancer Research and Treatment (2023) Vol. 56, Iss. 1, pp. 280-293
Open Access | Times Cited: 4

Disease models in colorectal cancer research
Swapnil Raut, Lokesh Kumar Bhatt, Aman Upaganlawar, et al.
Elsevier eBooks (2024), pp. 457-473
Closed Access | Times Cited: 1

Research advances in branched-chain amino acid metabolism in tumors
Zheng Li, Sainan Chen, Xiaoyan Wu, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 1

Proximal Protein Interaction Landscape of RAS Paralogs
Benoît Béganton, Étienne Coyaud, Estelle Laurent, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3326-3326
Open Access | Times Cited: 9

Quantitative Proteomic Approach Reveals Altered Metabolic Pathways in Response to the Inhibition of Lysine Deacetylases in A549 Cells under Normoxia and Hypoxia
Alfonso Martín-Bernabé, Josep Tarragó‐Celada, Valérie Cunin, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 7, pp. 3378-3378
Open Access | Times Cited: 5

Integrative omics analysis reveals relationships of genes with synthetic lethal interactions through a pan-cancer analysis
Li Guo, Sunjing Li, Bowen Qian, et al.
Computational and Structural Biotechnology Journal (2020) Vol. 18, pp. 3243-3254
Open Access | Times Cited: 4

Molecular Mechanisms and Potential Predictive Biomarkers in Advanced Non-small Cell Lung Cancer: A Summary of Current and Future Trends
S. Stella Jenifer Isabella, Beal Juliana Rodrigues, M. Edwin Fernando
Archives of Surgery and Clinical Research (2024) Vol. 8, Iss. 1, pp. 039-061
Closed Access

Ferroptosis-related LINC02535/has-miR-30c-5p/EIF2S1 axis as a novel prognostic biomarker involved in immune infiltration and progression of PDAC
Zhiwei Huang, Mo Li, Boyuan Gu, et al.
Cellular Signalling (2024) Vol. 123, pp. 111338-111338
Closed Access

Synthetic gene circuits that selectively target RAS-driven cancers
Gabriel Senn, Leon Nissen, Yaakov Benenson
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

HSc70 interactome reveal major role of macroautophagy and minor role of chaperone mediated autophagy in K-Ras G12V cell proliferation and survival
Vipin Yadav, Poorwa Awasthi, Rachna Behl, et al.
Journal of Proteomics (2022) Vol. 264, pp. 104614-104614
Closed Access | Times Cited: 2

Identification of Driver Genes in Primary Liver Cancer by Integrating NGS and TCGA Mutation Data
Lin Li, Lin Niu, Na Guo, et al.
Open Journal of Gastroenterology (2022) Vol. 12, Iss. 01, pp. 1-18
Open Access | Times Cited: 1

Page 1

Scroll to top